ASSAY RECORD
Results
Showing up to 20 records.
| NO. | RECORD ID | NAME | SEQUENCE | SOURCE ORGANISM | FUNCTION CATEGORY | TARGET ORGANISM | ACTIVITY | ASSAY METHOD | PMID | PATENT NO | VERIFICATION STATUS |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 390941 | Rec_0399271 | Putative conotoxin-like peptide |
MHIKAILLFVILTAANYGALACTETGRNCKYSYECCSGACSAAFGFCLHR |
Mamestra configurata nucleopolyhedrovirus B [Virus] |
Toxin |
- |
- | - |
- | - |
NO |
| 390942 | Rec_0399272 | Unnamed |
EIGKFLHSAKXFGKAFVXEIXNS |
synthetic construct [Synthetic] |
Antimicrobial |
- |
- | - |
- | US 10464975 B2 |
NO |
| 390943 | Rec_0399273 | PTP1 |
LLAGLAANFLPTIICKISYKC |
Glandirana rugosa [Animal] |
Anticancer, Cytotoxic |
A-549 |
>100 μg/mL | IC50 |
14499271 | - |
YES |
| 390944 | Rec_0399274 | Unnamed |
AKFEELNMDLFR |
not reported [other] |
Predicted/benchmark label: Immunomodulatory, Allergenicity |
- |
- | - |
37020337 | - |
NO |
| 390945 | Rec_0399275 | Unnamed |
GFFALIPKIISSPLFKTLLSAVGSAL |
not reported [other] |
Toxic, Hemolytic, Cytotoxic |
- |
- | - |
24174543 | - |
NO |
| 390946 | Rec_0399276 | LL-37 KR-12 [Q5A,D9A,F10A] |
KRIVARIKAALR |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial, Antifungal |
Escherichia coli ATCC 25922 |
2.5 μM | MIC |
29430821 | - |
YES |
| 390947 | Rec_0399277 | Unnamed |
GSECRSSCRLTNISITVESEECGSCITIDTTACAGLCKTQESVYRSPLMLSYQNTCNFREWTYETYEFKGCPARADSVFTYPVALSCECSKCNSDITDCGALSQQTLSCNAH |
not reported [other] |
Metabolic |
- |
- | - |
39514414 | - |
NO |
| 390948 | Rec_0399278 | Buffalo hepcidin |
DTHFPICIFCCGCCHKSKCGICCKT |
Glossophaga soricina [Animal] |
Antimicrobial, Antibacterial |
Escherichia coli TOP10 |
- | Mex pooled growth assay (OD_ID at 4.5 h; Wald adjusted p-value) |
35260685 | - |
YES |
| 390949 | Rec_0399279 | gamma-Lipotropin |
ELASEIIAAEDEEKAQEVAEEEQLHEKKDGTYKMKHFRWGGSPAS |
Dicentrarchus labrax [Animal] |
Neuropeptide |
- |
- | - |
- | - |
NO |
| 390950 | Rec_0399280 | Bacteriocin Pediocin[M31D] |
KYYGNGVTCGKHSCSVDWGKATTCIINNGADAWATGGHQGNHKC |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
Loigolactobacillus coryniformis subsp. torquens NCDO 2740 |
0.01 μM | MIC |
11055926 | - |
YES |
| 390951 | Rec_0399281 | Unnamed |
CKGRGKRCREKQRPSDKPRR |
synthetic construct [Synthetic] |
Antimicrobial, Anticancer |
- |
- | - |
- | US 20030186868 A1 |
NO |
| 390952 | Rec_0399282 | Mersacidin |
CTFTLPGGGGVCTLTSECIC |
Bacillus sp [Bacterium] |
Antimicrobial |
Staphylococcus aureus 209P |
1.56 μg/mL | MIC |
1500348 | - |
YES |
| 390953 | Rec_0399283 | SLAY-screened peptide P1814 |
CRRVNAYRPIKSSGSQNSLY |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
recombinant Escherichia coli surface-display screening |
- | SLAY screening |
29307492 | - |
NO |
| 390954 | Rec_0399284 | 16(derived from FIV envelope glycoprotein ) |
PNQTCMWNTSQIQDPEIPKC |
synthetic construct [Synthetic] |
Antimicrobial, Antiviral |
- |
- | - |
8661378 | - |
NO |
| 390955 | Rec_0399285 | Casein beta [193-198] |
HQIYPV |
Homo sapiens [Animal] |
Enzyme inhibitory, ACE inhibitory |
Angiotensin-I converting enzyme |
414.0 μM | IC50 |
- | - |
YES |
| 390956 | Rec_0399286 | LP-50 |
YTSLIEELIKKSEEQQKKNEEELKKLEX |
synthetic construct [Synthetic] |
Antiviral, Anti-HIV, Fusion inhibition |
HIV-2 (ROD,ST) | TZM-bl cells |
0.00009-0.00581 μM | IC50 |
30089693 | - |
YES |
| 390957 | Rec_0399287 | Unnamed |
VRIRARRVILVA |
synthetic construct [Synthetic] |
Antimicrobial, Antibacterial |
- |
- | - |
- | US 2008/0207522 A1 |
NO |
| 390958 | Rec_0399288 | Unnamed |
ILGTILKLLKFL |
synthetic construct [Synthetic] |
Antimicrobial |
- |
- | - |
- | WO 2020/061306 A1 |
NO |
| 390959 | Rec_0399289 | Peptide 9 |
IEKDRSRGIF |
synthetic construct [Synthetic] |
Antimicrobial,Antibacterial,Anti-Gram-positive,Anti-Gram-negative |
Micrococcus luteus |
6890 μM | MIC |
29221796 | - |
YES |
| 390960 | Rec_0399290 | EK1 |
SLDQINVTFLDLEYEMKKLEEAIKKLEESYIDLKEL |
synthetic construct [Synthetic] |
Antiviral, Anti-SARS-CoV-2, Fusion inhibition |
SARS-CoV-2; 293T/ACE2 cells; VERO-E6 cells |
2.468 μM | IC50 |
32231345 | - |
YES |